-
DiI (DiIC18(3)) Membrane Probe Guide
2026-08-17
DiI (DiIC18(3)) provides orange-red labeling of lipid membranes for live or fixed-cell imaging, neuronal tracing, migration studies, and membrane-associated assays. It is appropriate for plasma membrane workflows but should not be used in water-only formulations or interpreted as an organelle-specific intracellular stain.
-
LY2603618 Chk1 Inhibitor: Practical Research Guide
2026-08-16
Build mechanism-resolved DNA damage and cell-cycle assays with LY2603618, a selective Chk1 inhibitor suited to cancer-cell and chemotherapy-sensitization research. This guide connects dose selection, γH2AX and G2/M readouts, combination experiments, and troubleshooting with insights from a PARP1-trapping study.
-
Linoleic Acid C18:2: Practical Assay Guidance
2026-08-15
Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a defined lipid reagent for oxidative stress, membrane, migration, erythrocyte, and essential fatty acid studies. It is suitable for freshly prepared, solvent-based workflows, but not for direct aqueous preparation or long-term storage of solution stocks.
-
RG7388: From p53 Reactivation to Assay Design
2026-08-14
RG7388 is a selective MDM2 antagonist for studying p53 pathway activation, apoptosis, and treatment sensitivity. This article connects its pharmacology with MDM1-based chemoradiotherapy research to provide a practical framework for model selection, combination assays, and interpretation.
-
Fluoxetine HCl: Applied Neuroscience Workflows
2026-08-14
Fluoxetine HCl connects transporter pharmacology with receptor-current assays, neurogenesis and synaptic plasticity studies, and translational motivation paradigms. This workflow-focused guide shows how to formulate, dose, validate, and troubleshoot the compound without confusing acute serotonergic effects with developmental or behavioral conclusions.
-
Sumatriptan Metabolism: CYP and MAO Revisited
2026-08-13
The reference study revisits the accepted metabolic pathway of sumatriptan and shows that cytochrome P450 enzymes can contribute to N-demethylation alongside monoamine oxidase A. Its recombinant-enzyme and HPLC–MS design identifies a sequential CYP–MAO pathway that refines interpretation of sumatriptan biotransformation and drug-metabolite exposure.
-
Nocodazole for Microtubule Dynamics Research
2026-08-13
Nocodazole provides a reversible way to perturb microtubule assembly, making it useful for trafficking, cell-cycle, cancer, and pathogen-entry assays. This workflow translates findings from Spiroplasma eriocheiris infection research into practical controls for separating cytoskeletal dependence from nonspecific toxicity.
-
Pioglitazone: PPARγ Assays and Workflow Guide
2026-08-12
Use Pioglitazone as a controlled PPARγ agonist to connect metabolic signaling with macrophage polarization, intestinal inflammation, and beta-cell protection. This guide translates published DSS-model findings into practical cell, tissue, and troubleshooting workflows while separating evidence-backed parameters from optimization starting points.
-
Tetrandrine Workflows for Ion Channel Research
2026-08-12
Tetrandrine combines calcium-channel activity with practical DMSO handling for cell-based, biochemical, and membrane-transport assays. This guide turns its formulation and pharmacology into reproducible workflows, while using natural-product screening principles to improve controls and interpretation.
-
3-(1-methylpyrrolidin-2-yl)pyridine (N2703) Workflows
2026-08-11
Build more interpretable pathway, signaling, and analytical assays with 3-(1-methylpyrrolidin-2-yl)pyridine (N2703). This guide emphasizes concentration design, pathway reconstitution, product verification, and troubleshooting rather than treating a small molecule as a substitute for genetic or biochemical evidence.
-
3-Deazaadenosine and the Methylation Control Point
2026-08-11
A translational perspective on how 3-Deazaadenosine converts SAH hydrolase inhibition into a systems-level methylation perturbation, and how that tool can help connect m6A biology, fibrosis mechanisms, and preclinical antiviral research without overstating pathway specificity.
-
Sodium Citrate B7298 for Reliable Cell Assays
2026-08-10
Learn how Sodium Citrate (SKU B7298) can improve control of pH, divalent-metal availability, and reagent handling in cell viability, proliferation, cytotoxicity, and biochemical workflows. This scenario-based guide separates validated product specifications from assay-specific recommendations and explains how to qualify citrate without masking biological effects.
-
Entinostat: Measuring Cancer Drug Response Better
2026-08-09
Entinostat (MS-275) is a selective class I HDAC inhibitor with broad relevance to cancer research. This guide explains how to distinguish growth arrest from cell killing so HDAC-response assays produce more interpretable biological and translational data.
-
Simvastatin (Zocor) Research Workflows
2026-08-08
Simvastatin (Zocor) supports reproducible studies of cholesterol biosynthesis, hepatic cancer phenotypes, endothelial signaling, and drug transport. This practical guide combines formulation control, time-resolved assay design, and reference-informed troubleshooting for stronger lipid and apoptosis readouts.
-
Ibrexafungerp: From pH Biology to Assay Design
2026-08-07
Ibrexafungerp is an oral triterpenoid antifungal with activity against Candida under clinically relevant acidic conditions. This article translates pH-sensitive susceptibility data into a practical framework for assay selection, resistance interpretation, and preclinical model design.